The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
Authors
Keywords
-
Journal
BMC Nephrology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-21
DOI
10.1186/s12882-019-1599-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of the alternative pathway of complement activation in glomerular diseases
- (2018) Emilia Łukawska et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab
- (2018) Anja Gäckler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers
- (2018) Chantal Dumestre-Pérard et al. AUTOIMMUNITY REVIEWS
- The complement system as a potential therapeutic target in rheumatic disease
- (2017) Leendert A. Trouw et al. Nature Reviews Rheumatology
- Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence
- (2017) Savino Sciascia et al. RHEUMATOLOGY INTERNATIONAL
- Infections associated with the use of eculizumab
- (2016) Esther Benamu et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Update on the pathogenesis and treatment of childhood-onset systemic lupus erythematosus
- (2016) Julie Couture et al. CURRENT OPINION IN RHEUMATOLOGY
- Success and failure of biological treatment in systemic lupus erythematosus: A critical analysis
- (2016) Mariele Gatto et al. JOURNAL OF AUTOIMMUNITY
- Complement receptor of the immunoglobulin superfamily reduces murine lupus nephritis and cutaneous disease
- (2015) Linda A. Lieberman et al. CLINICAL IMMUNOLOGY
- Pathogenesis of Renal Disease in Systemic Lupus Erythematosus—The Role of Autoantibodies and Lymphocytes Subset Abnormalities
- (2015) Desmond Yap et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Of mice and men: The factor H protein family and complement regulation
- (2015) R.B. Pouw et al. MOLECULAR IMMUNOLOGY
- Lupus Nephritis: The Evolving Role of Novel Therapeutics
- (2014) Brad H. Rovin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Lupus nephritis
- (2014) Georg Lorenz et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- A novel CRIg-targeted complement inhibitor protects cells from complement damage
- (2014) Qian Qiao et al. FASEB JOURNAL
- Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy
- (2014) Rosanna Coppo et al. PEDIATRIC NEPHROLOGY
- Immunopathology of lupus nephritis
- (2014) Hans-Joachim Anders et al. Seminars in Immunopathology
- Targeting the complement system in systemic lupus erythematosus and other diseases
- (2013) Maria-Louise Barilla-LaBarca et al. CLINICAL IMMUNOLOGY
- The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice
- (2011) Hideharu Sekine et al. ARTHRITIS AND RHEUMATISM
- Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis
- (2011) N Sato et al. LUPUS
- Markers of childhood lupus nephritis indicating disease activity
- (2010) Monika Edelbauer et al. PEDIATRIC NEPHROLOGY
- The complement system in systemic autoimmune disease
- (2009) Min Chen et al. JOURNAL OF AUTOIMMUNITY
- Usefulness of ISN/RPS Classification of Lupus Nephritis
- (2009) Ken-Ei Sada et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A role of macrophage complement receptor CRIg in immune clearance and inflammation
- (2008) Jeannie Q. He et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now